Abu Samaan TM, Samec M, Liskova A, Kubatka P, Büsselberg D (2019) Paclitaxel’s mechanistic and clinical effects on breast cancer. Biomolecules 9(12):789
Ashrafizadeh M, Mirzaei S, Gholami MH, Hashemi F, Zabolian A, Raei M, Hushmandi K, Zarrabi A, Voelcker NH, Aref AR, Hamblin MR, Varma RS, Samarghandian S, Arostegi IJ, Alzola M, Kumar AP, Thakur VK, Nabavi N, Makvandi P, Tay FR, Orive G (2021) Hyaluronic acid-based nanoplatforms for doxorubicin: a review of stimuli-responsive carriers, co-delivery and resistance suppression. Carbohydr Polym 272:118491
Bajpai S, Tiwary SK, Sonker M, Joshi A, Gupta V, Kumar Y, Shreyash N, Biswas S (2021) Recent advances in nanoparticle-based cancer treatment: a review. ACS App Nano Mater 4(7):6441–6470
Behzadi S, Serpooshan V, Tao W, Hamaly MA, Alkawareek MY, Dreaden EC, Brown D, Alkilany AM, Farokhzad OC, Mahmoudi M (2017) Cellular uptake of nanoparticles: journey inside the cell. Chem Soc Rev 46(14):4218–4244
Bosire R, Nánási P Jr, Imre L, Dienes B, Szöőr Á, Mázló A, Kovács A, Seidel R, Vámosi G, Szabó G (2019) Intercalation of small molecules into DNA in chromatin is primarily controlled by superhelical constraint. PLoS One 14(11):e0224936
Casalini T, Rossi F, Castrovinci A, Perale G (2019) A perspective on polylactic acid-based polymers use for nanoparticles synthesis and applications. Front Bioeng Biotechnol. https://doi.org/10.3389/fbioe.2019.00259
Corti A, Sacchi A, Gasparri AM, Monieri M, Anderluzzi G, Colombo B, Gori A, Mondino A, Curnis F (2021) Enhancement of doxorubicin anti-cancer activity by vascular targeting using IsoDGR/cytokine-coated nanogold. J Nanobiotechnol 19(1):128
El Laithy M, Wang L, Harvey TJ, Vierneusel B (2021) Semi-empirical model for predicting LAB and HAB formation in bearing steels. Int J Fatigue 148:106230
Essa D, Kondiah PPD, Choonara YE, Pillay V (2020) The design of poly(lactide-co-glycolide) nanocarriers for medical applications. Front Bioeng Biotechnol 8:48–48
Falzone L, Salomone S, Libra M (2018) Evolution of cancer pharmacological treatments at the turn of the third millennium. Front Pharmacol. https://doi.org/10.3389/fphar.2018.01300
Gazzi A, Fusco L, Khan A, Bedognetti D, Zavan B, Vitale F, Yilmazer A, Delogu LG (2019) Photodynamic therapy based on graphene and MXene in cancer theranostics. Front Bioeng Biotechnol. https://doi.org/10.3389/fbioe.2019.00295
Geraili A, Xing M, Mequanint K (2021) Design and fabrication of drug-delivery systems toward adjustable release profiles for personalized treatment. View 2(5):20200126
Gou J, Liang Y, Miao L, Guo W, Chao Y, He H, Zhang Y, Yang J, Wu C, Yin T, Wang Y, Tang X (2017) Improved tumor tissue penetration and tumor cell uptake achieved by delayed charge reversal nanoparticles. Acta Biomater 62:157–166
Hoshyar N, Gray S, Han H, Bao G (2016) The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction. Nanomedicine (Lond) 11(6):673–692
Hussain Y, Islam L, Khan H, Filosa R, Aschner M, Javed S (2021) Curcumin–cisplatin chemotherapy: A novel strategy in promoting chemotherapy efficacy and reducing side effects. Phytother Res 35(12):6514–6529
Jenita JJL, Tibrewal R, Rathore SS, Manjula D, Barnabas W, Mahesh AR (2021) Formulation and optimization of albumin nanoparticles loaded ivabradine hydrochloride using response surface design. J Drug Deliv Sci Technol 63:102461
Jin J, Zhao Q (2020) Engineering nanoparticles to reprogram radiotherapy and immunotherapy: recent advances and future challenges. J Nanobiotechnol 18(1):75
Kennedy L, Sandhu JK, Harper M-E, Cuperlovic-Culf M (2020) Role of glutathione in cancer: from mechanisms to therapies. Biomolecules 10(10):1429
Li X, Wang L, Fan Y, Feng Q, Cui F-Z (2012) Biocompatibility and toxicity of nanoparticles and nanotubes. J Nanomater 2012:548389
Li C, Zhang D, Guo H, Hao L, Zheng D, Liu G, Shen J, Tian X, Zhang Q (2013) Preparation and characterization of galactosylated bovine serum albumin nanoparticles for liver-targeted delivery of oridonin. Int J Pharm 448(1):79–86
Li Z, Chen Y, Yang Y, Yu Y, Zhang Y, Zhu D, Yu X, Ouyang X, Xie Z, Zhao Y, Li L (2019) Recent advances in nanomaterials-based chemo-photothermal combination therapy for improving cancer treatment. Front Bioeng Biotechnol. https://doi.org/10.3389/fbioe.2019.00293
Ma Y, Yu S, Ni S, Zhang B, Kung ACF, Gao J, Lu A, Zhang G (2021) Targeting strategies for enhancing paclitaxel specificity in chemotherapy. Front Cell Dev Biol. https://doi.org/10.3389/fcell.2021.626910
Mahalakshmi N, Rajavel R (2014) Synthesis, spectroscopic, DNA cleavage and antibacterial activity of binuclear schiff base complexes. Arab J Chem 7(4):509–517
Xavier HF, Nadar VM, Patel P, Umapathy D, Joseph AV, Manivannan S, Santhiyagu P, Pandi B, Muthusamy G, Rathinam Y, Ponnuchamy K (2020) Selective antibacterial and apoptosis-inducing effects of hybrid gold nanoparticles–A green approach. J Drug Deliv Sci Technol. 1(59):101890
Mohapatra A, Uthaman S, Park I-K (2021) External and internal stimuli-responsive metallic nanotherapeutics for enhanced anticancer therapy. Front Mol Biosci. https://doi.org/10.3389/fmolb.2020.597634
Moore TL, Urban DA, Rodriguez-Lorenzo L, Milosevic A, Crippa F, Spuch-Calvar M, Balog S, Rothen-Rutishauser B, Lattuada M, Petri-Fink A (2019) Nanoparticle administration method in cell culture alters particle-cell interaction. Sci Rep 9(1):900
Nakamura Y, Mochida A, Choyke PL, Kobayashi H (2016) Nanodrug delivery: is the enhanced permeability and retention effect sufficient for curing cancer? Bioconjug Chem 27(10):2225–2238
Nath B, Raza A, Sethi V, Dalal A, Ghosh SS, Biswas G (2018) Understanding flow dynamics, viability and metastatic potency of cervical cancer (HeLa) cells through constricted microchannel. Sci Rep 8(1):17357
Osman S, Raza A, Al-Zaidan L, Inchakalody VP, Merhi M, Prabhu KS, Abdelaziz N, Hydrose S, Uddin S, Dermime S (2021) Anti-cancer effects of l update. Biomed Pharmacother 141:111844
Patra JK, Das G, Fraceto LF, Campos EV, Rodriguez-Torres MD, Acosta-Torres LS, Diaz-Torres LA, Grillo R, Swamy MK, Sharma S, Habtemariam S (2018) Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnol 16(1):1–33
Plucinski A, Lyu Z, Schmidt BVKJ (2021) Polysaccharide nanoparticles: from fabrication to applications. J Mater Chemi B 9(35):7030–7062
Raza F, Zafar H, Khan MW, Ullah A, Khan AU, Baseer A, Fareed R, Sohail M (2022) Recent advances in the targeted delivery of paclitaxel nanomedicine for cancer therapy. Mater Adv 3(5):2268–2290
Rejeeth C, Nag TC, Kannan S (2013) Cisplatin-functionalized silica nanoparticles for cancer chemotherapy. Cancer Nanotechnol 4(6):127–136
Sharma S, Parveen R, Chatterji BP (2021) Toxicology of nanoparticles in drug delivery. Curr Pathobiol Rep 9(4):133–144
Shu C, Sabi-mouka EMB, Yang W, Li Z, Ding L (2016) Effects of paclitaxel (PTX) prodrug-based self-assembly peptide hydrogels combined with suberoylanilide hydroxamic acid (SAHA) for PTX-resistant cancer and synergistic antitumor therapy. RSC Adv 6(103):100765–100771
Siegel RL, Miller KD, Fuchs HE, Jemal A (2021) Cancer statistics, 2021. Ca Cancer J Clin 71(1):7–33
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countrie. CA Cancer J Clin 71(3):209–249
Tang H, Zhao W, Yu J, Li Y, Zhao C (2018) Recent development of pH-responsive polymers for cancer nanomedicine. Molecules 24(1):4
Wang Z, Wang Z, Lu WW, Zhen W, Yang D, Peng S (2017) Novel biomaterial strategies for controlled growth factor delivery for biomedical applications. NPG Asia Mater 9(10):e435–e435
Wang D, Liang N, Kawashima Y, Cui F, Yan P, Sun S (2019) Biotin-modified bovine serum albumin nanoparticles as a potential drug delivery system for paclitaxel. J Mater Sci 54(11):8613–8626
Yadav P, Yadav AB (2021) Preparation and characterization of BSA as a model protein loaded chitosan nanoparticles for the development of protein-/peptide-based drug delivery system. Future J Pharm Sci 7(1):200
Zhang Q, Lu Q-B (2021) New combination chemotherapy of cisplatin with an electron-donating compound for treatment of multiple cancers. Sci Rep 11(1):788
Zhu Y, Huang Y, Liu M, Yan Q, Zhao W, Yang P, Gao Q, Wei J, Zhao W, Ma L (2019) Epigallocatechin gallate inhibits cell growth and regulates miRNA expression in cervical carcinoma cell lines infected with different high-risk human papillomavirus subtypes. Exp Ther Med 17(3):1742–1748
留言 (0)